Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Reexamination Certificate
2007-07-31
2007-07-31
Aulakh, Charanjit S. (Department: 1625)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
C546S122000
Reexamination Certificate
active
11284660
ABSTRACT:
Compounds are disclosed which are Fab I inhibitors and are useful in the treatment bacterial infections.
REFERENCES:
patent: 3828068 (1974-08-01), Minieri
patent: 4154943 (1979-05-01), Kuehne
patent: 4977159 (1990-12-01), Sevrin et al.
patent: 5614551 (1997-03-01), Dick et al.
patent: 5624941 (1997-04-01), Barth et al.
patent: 5932743 (1999-08-01), Collini et al.
patent: 5985867 (1999-11-01), Rodgers et al.
patent: 6346391 (2002-02-01), Oethinger et al.
patent: 6372752 (2002-04-01), Staveski et al.
patent: 6451816 (2002-09-01), Biedermann et al.
patent: 6469046 (2002-10-01), Daines et al.
patent: 6503903 (2003-01-01), Miller et al.
patent: 6503908 (2003-01-01), Maw
patent: 6559172 (2003-05-01), Heerding et al.
patent: 6573272 (2003-06-01), Miller et al.
patent: 6673941 (2004-01-01), Heerding et al.
patent: 6730684 (2004-05-01), Miller et al.
patent: 6762201 (2004-07-01), Miller et al.
patent: 6765005 (2004-07-01), Miller et al.
patent: 6846819 (2005-01-01), Miller et al.
patent: 6964970 (2005-11-01), Miller et al.
patent: 7048926 (2006-05-01), Brandt et al.
patent: 7049310 (2006-05-01), Burgess et al.
patent: 2005/0250810 (2005-11-01), Miller et al.
patent: 2006/0142265 (2006-06-01), Berman et al.
patent: 2006/0183908 (2006-08-01), Berman et al.
patent: WO 98/57952 (1998-12-01), None
patent: C-107200 (1990-05-01), None
patent: WO 95/18619 (1995-07-01), None
patent: WO 96/00730 (1996-01-01), None
patent: WO 97/48696 (1997-12-01), None
patent: WO 01/26652 (2001-04-01), None
patent: WO 01/26654 (2001-04-01), None
patent: WO 01/27103 (2001-04-01), None
patent: WO 01/48248 (2001-07-01), None
patent: WO 02/42273 (2002-05-01), None
patent: WO 02/48097 (2002-06-01), None
Abou-Gharbia et al., “Psychotropic Agents: Synthesis and Antipysychotic Activity of Substituted B-Carbolines,” J. Med. Chem., 30(6):1100-1115 (1987).
Ahsan et al., “Reserpine Anlogues: Synthesis of B-Carboline Derivatives,” J. Chem. Soc., pp. 3928-3920 (1963).
Database CA on STN, AN 7:66733, Rosenmund et al., “Chemistry of indole II . . . ,”Chem Ber. 103(2): 496-509 (1970).
Database CAOLD on STN, AN CA51:10524d, Hellman et al., “N-Mannich bases (VI) condensation . . . ,”Direct Submission(1953).
Database CAPLUS on STN, An 1977:439214. Misztal et al., “Synthesis and pharmacologic properties of pyridoyl . . . ,”Arch Immuno Ther Exp. 24(6): 851-862 (1976).
DATABASE Crossfire Beilstein, 1966, Database accession No. 2819049, 2819050, XP002216033.
Himmer et al., “Synthesis and Antibacterial in Vitro Activity of Novel Analogues of Nematophin,” Bioorganic & Medicinal Chemistry Letters, 8(15):2045-2050 (Aug. 1998).
Jianxiong et al., “Synthesis and Antistaphylococcal Activity of Nematophin and Its Analogs,” Bioorganic & Medicinal Chemistry Letters, Oxford, GB, 7(10): 1349-1352, (May 20, 1977) XP004136332.
Miller et al., Discovery of Aminopyridine-Based Inhibitors of Bacterial Enoyl-ACP Reductase (FABI); J. Med. Chem. 2002, vol. 45, pp. 3246-3256.
Misztal et al., “Synthesis and Pharmacologic Properties of Pyridol Derivatives of 3-Methylaminoindole 2-Methyltryptaminc and Isotryptamine,” Archivum Immnologlae et Therapiae Experimentalis, 24(6): 851-852 (1976).
Pachter et al., “The Chemistry of Hortlamine and 6-Methoxyhetsinine,” J. Amer. Chem., 83:635-642 (1961).
Rehse et al., “Dopaminanaloge 1,2,3,4-Tetrahydro-B-Carboline,” Arch. Pharm., 311(1):11-18 (1978).
Shoji et al., “Two Novel Alkaloids from Evodia Rutaecarpa,” J. Natural Products, 52(5):1160-1162 (1989).
Stütz et al., “Synthesis and Structure-Activity Relationships of Naftifine-Related Allylamine Antimycotics,” Journal of Medicinal Chemistry, 1986, vol. 29, No. 1, 112-125.
Burgess Walter J.
Huffman William F.
Jakas Dalia R.
Miller William H.
Newlander Kenneth A.
Affinium Pharmaceuticals, Inc.
Goodwin & Procter LLP
LandOfFree
Fab I inhibitors does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Fab I inhibitors, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Fab I inhibitors will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3776885